{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:20:46Z","timestamp":1790871646314,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,13]]},"DOI":"10.7759\/cureus.96801","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T06:23:27Z","timestamp":1763101407000},"source":"Crossref","is-referenced-by-count":3,"title":["Unraveling the Association Between Fibromyalgia and Irritable Bowel Syndrome: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Roshitha  S","family":"Bheemaneni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Sakarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aahana","family":"Nigam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangeline C","family":"Nwachukwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Sekar Lakshmisai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11102594","article-title":"Prevalence of fibromyalgia and chronic fatigue syndrome among individuals with irritable bowel syndrome: an analysis of united states national inpatient sample database","volume":"11","author":"Tarar ZI","year":"2023","unstructured":"Tarar ZI, Farooq U, Nawaz A, Gandhi M, Ghouri YA, Bhatt A, Cash BD. Prevalence of fibromyalgia and chronic fatigue syndrome among individuals with irritable bowel syndrome: an analysis of united states national inpatient sample database. Biomedicines. 2023, 11:2594. 10.3390\/biomedicines11102594","journal-title":"Biomedicines"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11030809","article-title":"Association among disorders of gut-brain interaction (DGBI) and fibromyalgia: a prospective study","volume":"11","author":"Settembre C","year":"2022","unstructured":"Settembre C, D'Antonio E, Moscato P, Loi G, Santonicola A, Iovino P. Association among disorders of gut-brain interaction (DGBI) and fibromyalgia: a prospective study. J Clin Med. 2022, 11:809. 10.3390\/jcm11030809","journal-title":"J Clin Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.15428","article-title":"Epidemiology of Fibromyalgia: East Versus West","volume":"27","author":"Soroosh S","year":"2024","unstructured":"Soroosh S. Epidemiology of Fibromyalgia: East Versus West. Int J Rheum Dis. 2024, 27:e15428. 10.1111\/1756-185X.15428","journal-title":"Int J Rheum Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2023.00199","article-title":"Diagnostic strategy of irritable bowel syndrome: a low- and middle-income country perspective","volume":"22","author":"Hidayat AA","year":"2024","unstructured":"Hidayat AA, Waskito LA, Sugihartono T, Aftab H, Rezkitha YA, Vilaichone RK, Miftahussurur M. Diagnostic strategy of irritable bowel syndrome: a low- and middle-income country perspective. Intest Res. 2024, 22:286-96. 10.5217\/ir.2023.00199","journal-title":"Intest Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2019.01.019","article-title":"Time to diagnosis of fibromyalgia and factors associated with delayed diagnosis in primary care","volume":"32","author":"Gendelman O","year":"2018","unstructured":"Gendelman O, Amital H, Bar-On Y, et al.. Time to diagnosis of fibromyalgia and factors associated with delayed diagnosis in primary care. Best Pract Res Clin Rheumatol. 2018, 32:489-99. 10.1016\/j.berh.2019.01.019","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/ta9xtc","article-title":"Delay in fibromyalgia diagnosis and its impact on the severity and outcome: a large cohort study","volume":"42","author":"Salaffi F","year":"2024","unstructured":"Salaffi F, Farah S, Bianchi B, Lommano MG, Di Carlo M. Delay in fibromyalgia diagnosis and its impact on the severity and outcome: a large cohort study. Clin Exp Rheumatol. 2024, 42:1198-204. 10.55563\/clinexprheumatol\/ta9xtc","journal-title":"Clin Exp Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29923","article-title":"A correlation between the pathogenic processes of fibromyalgia and irritable bowel syndrome in the middle-aged population: a systematic review","volume":"14","author":"Valencia C","year":"2022","unstructured":"Valencia C, Fatima H, Nwankwo I, et al.. A correlation between the pathogenic processes of fibromyalgia and irritable bowel syndrome in the middle-aged population: a systematic review. Cureus. 2022, 14:e29923. 10.7759\/cureus.29923","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11061701","article-title":"Fibromyalgia and irritable bowel syndrome interaction: a possible role for gut microbiota and gut-brain axis","volume":"11","author":"Garofalo C","year":"2023","unstructured":"Garofalo C, Cristiani CM, Ilari S, et al.. Fibromyalgia and irritable bowel syndrome interaction: a possible role for gut microbiota and gut-brain axis. Biomedicines. 2023, 11:1701. 10.3390\/biomedicines11061701","journal-title":"Biomedicines"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2016.08.012","article-title":"2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria","volume":"46","author":"Wolfe F","year":"2016","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, et al.. 2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016, 46:319-29. 10.1016\/j.semarthrit.2016.08.012","journal-title":"Semin Arthritis Rheum"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/ph17091205","article-title":"Association of the serotonin and kynurenine pathways as possible therapeutic targets to modulate pain in patients with fibromyalgia","volume":"17","author":"Alfaro-Rodr\u00edguez A","year":"2024","unstructured":"Alfaro-Rodr\u00edguez A, Reyes-Long S, Roldan-Valadez E, et al.. Association of the serotonin and kynurenine pathways as possible therapeutic targets to modulate pain in patients with fibromyalgia. Pharmaceuticals (Basel). 2024, 17:1205. 10.3390\/ph17091205","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/PR9.0000000000001224","article-title":"Decoding the connection: unraveling the role of gut microbiome in fibromyalgia","volume":"10","author":"Minerbi A","year":"2025","unstructured":"Minerbi A, Khoutorsky A, Shir Y. Decoding the connection: unraveling the role of gut microbiome in fibromyalgia. Pain Rep. 2025, 10:e1224. 10.1097\/PR9.0000000000001224","journal-title":"Pain Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12072558","article-title":"Irritable bowel syndrome and the gut microbiome: a comprehensive review","volume":"12","author":"Shaikh SD","year":"2023","unstructured":"Shaikh SD, Sun N, Canakis A, Park WY, Weber HC. Irritable bowel syndrome and the gut microbiome: a comprehensive review. J Clin Med. 2023, 12:2558. 10.3390\/jcm12072558","journal-title":"J Clin Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v11.i19.4458","article-title":"Molecular signalling during cross talk between gut brain axis regulation and progression of irritable bowel syndrome: a comprehensive review","volume":"11","author":"Singh SV","year":"2023","unstructured":"Singh SV, Ganguly R, Jaiswal K, Yadav AK, Kumar R, Pandey AK. Molecular signalling during cross talk between gut brain axis regulation and progression of irritable bowel syndrome: a comprehensive review. World J Clin Cases. 2023, 11:4458-76. 10.12998\/wjcc.v11.i19.4458","journal-title":"World J Clin Cases"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.13140\/2.1.1018.4643","article-title":"Guidance on the conduct of narrative synthesis in systematic reviews. A product from the ESRC methods programme Version","author":"Popay J","year":"2006","unstructured":"Popay J, Roberts H, Sowden A, et al.. Guidance on the Conduct of Narrative Synthesis in Systematic Reviews. ESRC Methods Programme, Swindon; 2006. 10.13140\/2.1.1018.4643"},{"key":"ref16","unstructured":"Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. (2021). Accessed: 2025: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea BJ","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, et al.. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017, 358:j4008. 10.1136\/bmj.j4008","journal-title":"BMJ"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA-a scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge C","year":"2019","unstructured":"Baethge C, Goldbeck-Wood S, Mertens S. SANRA-a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019, 4:5. 10.1186\/s41073-019-0064-8","journal-title":"Res Integr Peer Rev"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1186\/s40168-019-0656-z","article-title":"Evidence for an association of gut microbial Clostridia with brain functional connectivity and gastrointestinal sensorimotor function in patients with irritable bowel syndrome, based on tripartite network analysis","volume":"7","author":"Labus JS","year":"2019","unstructured":"Labus JS, Osadchiy V, Hsiao EY, et al.. Evidence for an association of gut microbial Clostridia with brain functional connectivity and gastrointestinal sensorimotor function in patients with irritable bowel syndrome, based on tripartite network analysis. Microbiome. 2019, 7:45.","journal-title":"Microbiome"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.07.031","article-title":"Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia","volume":"46","author":"Clos-Garcia M","year":"2019","unstructured":"Clos-Garcia M, Andr\u00e9s-Marin N, Fern\u00e1ndez-Eulate G, et al.. Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia. EBioMedicine. 2019, 46:499-511. 10.1016\/j.ebiom.2019.07.031","journal-title":"EBioMedicine"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/biom14121643","article-title":"The role of gut microbiome in irritable bowel syndrome: implications for clinical therapeutics","volume":"14","author":"Zhao Y","year":"2024","unstructured":"Zhao Y, Zhu S, Dong Y, et al.. The role of gut microbiome in irritable bowel syndrome: implications for clinical therapeutics. Biomolecules. 2024, 14:1643. 10.3390\/biom14121643","journal-title":"Biomolecules"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.817100","article-title":"Neurotransmitter and intestinal interactions: focus on the microbiota-gut-brain axis in irritable bowel syndrome","volume":"13","author":"Chen M","year":"2022","unstructured":"Chen M, Ruan G, Chen L, et al.. Neurotransmitter and intestinal interactions: focus on the microbiota-gut-brain axis in irritable bowel syndrome. Front Endocrinol (Lausanne). 2022, 13:817100. 10.3389\/fendo.2022.817100","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i1.46","article-title":"Increased intestinal mucosal leptin levels in patients with diarrhea-predominant irritable bowel syndrome","volume":"24","author":"Liu DR","year":"2018","unstructured":"Liu DR, Xu XJ, Yao SK. Increased intestinal mucosal leptin levels in patients with diarrhea-predominant irritable bowel syndrome. World J Gastroenterol. 2018, 24:46-57. 10.3748\/wjg.v24.i1.46","journal-title":"World J Gastroenterol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4274\/balkanmedj.galenos.2019.2019.6.47","article-title":"Elevated serum levels of monocyte chemotactic protein-1\/chemokine C-C motif ligand 2 are linked to disease severity in patients with fibromyalgia syndrome","volume":"36","author":"Zhao YC","year":"2019","unstructured":"Zhao YC, Hu T, Chen Y, Du KT. Elevated serum levels of monocyte chemotactic protein-1\/chemokine C-C motif ligand 2 are linked to disease severity in patients with fibromyalgia syndrome. Balkan Med J. 2019, 36:331-6. 10.4274\/balkanmedj.galenos.2019.2019.6.47","journal-title":"Balkan Med J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1887719","article-title":"The gut virome in irritable bowel syndrome differs from that of controls","volume":"13","author":"Coughlan S","year":"2021","unstructured":"Coughlan S, Das A, O'Herlihy E, Shanahan F, O'Toole PW, Jeffery IB. The gut virome in irritable bowel syndrome differs from that of controls. Gut Microbes. 2021, 13:1-15. 10.1080\/19490976.2021.1887719","journal-title":"Gut Microbes"},{"key":"ref26","article-title":"Gut microbiome: pertinence in fibromyalgia","volume":"38 Suppl 123","author":"Minerbi A","year":"2020","unstructured":"Minerbi A, Fitzcharles MA. Gut microbiome: pertinence in fibromyalgia. Clin Exp Rheumatol. 2020, 38 Suppl 123:99-104.","journal-title":"Clin Exp Rheumatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.5056\/jnm22129","article-title":"Bile acid and gut microbiota in irritable bowel syndrome","volume":"28","author":"Min YW","year":"2022","unstructured":"Min YW, Rezaie A, Pimentel M. Bile acid and gut microbiota in irritable bowel syndrome. J Neurogastroenterol Motil. 2022, 28:549-61. 10.5056\/jnm22129","journal-title":"J Neurogastroenterol Motil"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.06.051","article-title":"Vasoactive intestinal polypeptide and mast cells regulate increased passage of colonic bacteria in patients with irritable bowel syndrome","volume":"153","author":"Bednarska O","year":"2017","unstructured":"Bednarska O, Walter SA, Casado-Bedmar M, et al.. Vasoactive intestinal polypeptide and mast cells regulate increased passage of colonic bacteria in patients with irritable bowel syndrome. Gastroenterology. 2017, 153:948-60.e3. 10.1053\/j.gastro.2017.06.051","journal-title":"Gastroenterology"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v28.i4.412","article-title":"Gut bless you: the microbiota-gut-brain axis in irritable bowel syndrome","volume":"28","author":"Hillestad EM","year":"2022","unstructured":"Hillestad EM, van der Meeren A, Nagaraja BH, et al.. Gut bless you: the microbiota-gut-brain axis in irritable bowel syndrome. World J Gastroenterol. 2022, 28:412-31. 10.3748\/wjg.v28.i4.412","journal-title":"World J Gastroenterol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910235","article-title":"Enteric microbiota-mediated serotonergic signaling in pathogenesis of irritable bowel syndrome","volume":"22","author":"Mishima Y","year":"2021","unstructured":"Mishima Y, Ishihara S. Enteric microbiota-mediated serotonergic signaling in pathogenesis of irritable bowel syndrome. Int J Mol Sci. 2021, 22:10235. 10.3390\/ijms221910235","journal-title":"Int J Mol Sci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22062973","article-title":"Tryptophan metabolism and gut-brain homeostasis","volume":"22","author":"Roth W","year":"2021","unstructured":"Roth W, Zadeh K, Vekariya R, Ge Y, Mohamadzadeh M. Tryptophan metabolism and gut-brain homeostasis. Int J Mol Sci. 2021, 22:2973. 10.3390\/ijms22062973","journal-title":"Int J Mol Sci"},{"key":"ref32","article-title":"Probiotics","author":"Shahrokhi M","year":"2023","unstructured":"Shahrokhi M, Nagalli S. Probiotics. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i1.102","article-title":"Fecal microbiota transplantation broadening its application beyond intestinal disorders","volume":"21","author":"Xu MQ","year":"2015","unstructured":"Xu MQ, Cao HL, Wang WQ, Wang S, Cao XC, Yan F, Wang BM. Fecal microbiota transplantation broadening its application beyond intestinal disorders. World J Gastroenterol. 2015, 21:102-11. 10.3748\/wjg.v21.i1.102","journal-title":"World J Gastroenterol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.4236\/ojgas.2017.74015","article-title":"Fecal microbiota transplantation for fibromyalgia: a case report and review of the literature","volume":"7","author":"Thurm T","year":"2017","unstructured":"Thurm T, Ablin JN, Buskila D, Maharshak N. Fecal microbiota transplantation for fibromyalgia: a case report and review of the literature. Open J Gastroenterol. 2017, 7:151-8. 10.4236\/ojgas.2017.74015","journal-title":"Open J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/390141-unraveling-the-association-between-fibromyalgia-and-irritable-bowel-syndrome-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T06:23:28Z","timestamp":1763101408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/390141-unraveling-the-association-between-fibromyalgia-and-irritable-bowel-syndrome-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.96801","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,13]]}}}